<DOC>
	<DOCNO>NCT02269150</DOCNO>
	<brief_summary>The purpose study see fecal microbiota transplantation ( FMT ) prevent future development CDI . This also know fecal bacteriotherapy stool transplant .</brief_summary>
	<brief_title>Autologous Fecal Microbiota Transplantation ( Auto-FMT ) Prophylaxis Clostridium Difficile Infection Recipients Allogeneic Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>This randomize , open-label , control study design ass efficacy autologous fecal microbiota transplantation ( auto-FMT ) prevention Clostridium difficile infection ( CDI ) patient undergone allogeneic hematopoietic stem cell transplantation ( allo-HSCT ) . Patients enrol prior allo-HSCT ; feces collect store participate subject prior initiation conditioning regimen , analyze deep 16S rRNA gene sequencing , test assay intestinal pathogen include Clostridium difficile . Later course transplantation , follow engraftment ( define first day three consecutive day , absolute blood neutrophil count f 500 mm3 ) , subject undergo fecal test presence Bacteroidetes 16S PCR . Subjects eligible study microbiologically diverse pre-transplant colonic microbiota , post-engraftment specimen contain Bacteroidetes prevalence equal ( 0.1 % )</detailed_description>
	<criteria>Planned undergo alloHSCT Age â‰¥ 18 year As determined study investigator consent professional , prolong antibiotic treatment , prevention suppression ongoing infection , treatment involve gutperturbing antianaerobic antibiotic Has severe colitis etiology history inflammatory bowel disease ( IBD ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Recipients</keyword>
	<keyword>Transplantation</keyword>
</DOC>